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We report the development of dual stimuli-responsive nanoparticles with potential for 
anticancer therapy. The nanoparticles are composed of a conjugated polymer (polypyrrole, 













physicochemical techniques. The dual stimuli-responsive nature of the PPY nanoparticles 
was validated in vitro: the PPY nanoparticles delivered an anticancer drug (allicin) in 
response to exposure to an electric field in vitro as demonstrated with UV-vis spectroscopy; 
and the PPY nanoparticles exhibited photothermal activity upon irradiation with near infrared 
light which resulted in resulted in toxicity towards HEP G2 cells in vitro. We believe that 
such nanoparticles have long term potential for application in cancer therapy in a variety of 
tissue niches (e.g. breast cancer, liver cancer, lung cancer, skin cancer). 
Keywords: polypyrrole; nanoparticles; cancer; conjugated polymer; photothermal; stimuli-
responsive 
1. Introduction 
The global market for drug delivery systems is driven by an increasing demand for 
such technologies in both developed and emerging economies. The development of systems 
capable of controllably delivering drugs at rates determined by specific features of the 
systems, particularly those that respond to chemical stimuli (e.g. enzymes, ions, pH) or 
physical stimuli (e.g. electromagnetic fields, temperature) is an exciting avenue of research 
and development (Tibbit et al., 2015). A multitude of drug delivery systems that function via 
a single mechanism have been reported, and the development of drug delivery systems that 
function via multiple mechanisms (either via the delivery of a combination of therapeutics or 
in response to multiple stimuli) is an area of increasing investment in research and 
development. 
Conjugated polymers have interesting optoelectronic properties which has garnered 
significant industrial interest for their use in technical applications (particularly in the 
ubiquitous electronics industry) and medical applications (e.g. for use as bioactuators, 
biosensors, drug delivery devices, neural electrode coatings, or indeed tissue scaffolds for 













for biomedical applications are polyaniline, polypyrrole (PPY, Figure 1A) and 
polythiophene; and polyaniline- and PPY-based systems have been shown to deliver drugs 
with various structures (including anions and cations) in response to electrochemical triggers 
as described in excellent reviews (Pillay et al., 2014; Uppalapati et al., 2016). Furthermore, 
conjugated polymers have also been used to deliver drugs (e.g. the topoisomerase inhibitor 
Camptothecin) in response to near infrared (NIR) light (Wang et al., 2015). 
Cancer is one of the leading causes of death worldwide and its effective treatment is 
therefore the focus of research supported by charities, governments and industry (Abozeid et 
al., 2016). While traditional anticancer drug delivery systems can be effective in certain 
circumstances, the use of novel drug delivery systems that maximize the therapeutic efficacy 
of the drugs delivered, and potentially overcome resistance mechanisms and any associated 
side-effects of the therapeutics to be delivered is particularly appealing (Song et al., 2017). In 
this context, the conjugated PPY possesses good in-vitro and in-vivo biocompatibility, which 
responds to exposure to irradiation with NIR light, and electrochemical stimuli, offering 
potential for drug delivery in response to either light or electricity, and may eventually prove 
to be a useful component in multi-stimuli-responsive drug delivery devices used in in vivo 
cancer therapy (Wang et al., 2017; Chen et al. 2017).  NIR penetrates biological tissues 
deeply (typically to depths of multiple cm), with minimal/no harm to the tissues (Wang et al., 
2015). 
PPY can be synthesized in large quantities at room temperature in a wide range of 
aqueous or non-aqueous solvents either by solution phase or electrochemical polymerization. 
Electrochemical polymerization is appealing because it is cheap, reliable and green (Fonner 
et al., 2008; Balint et al., 2014); moreover, it is easy to load the polymer with a negatively 
charged drug (dopant) during the electrochemical polymerization. Hundreds of different 













1996). Allicin (diallyl thiosulfinate) is a bioactive component derived from garlic (Allium 
sativum) and ramsons (Allium ursinum) and has been reported to show a spectrum of 
therapeutic effects including antimicrobial, antifungal, antihypertensive, cardioprotective and 
anticancer (Borlinghaus et al., 2014); the latter being the focus of this study. The mechanisms 
underpinning the anticancer activity of allicin have been studied (Borlinghaus et al., 2014; 
Miron et al., 2008), and allicin has been observed to exhibit anticancer activity towards colon 
cancer (Bat-Chen et al., 2010), gastric cancer SGC-7901 cells (Sun et al., 2014), glioma cells 
(Li et al., 2018), human cervical cancer SiHa cells (Oommen., 2004), human epithelial 
carcinoma (Park et al., 2005), liver cancer (Chu et al., 2013), MCF-7 cells (Hirsch et al., 
2000), neuroblastoma (Zhuang et al., 2016), ovarian cancer (Xu et al., 2014), and pancreatic 
cancer (Wang et al., 2013). 
Here we report the development of dual stimuli-responsive nanoparticles based on the 
conjugated polymer PPY. The PPY nanoparticles were loaded with allicin and their ability to 
deliver allicin in response to the application of an electric field is demonstrated in vitro, and 
to exhibit photothermal toxicity towards HEP G2 cells in response to exposure to irradiation 
with near infrared light is demonstrated in vitro. 
2. Materials and Methods 
2.1. Materials 
Pyrrole, dimethyl sulfoxide (DMSO), phosphate buffered saline tablets (when 
dissolved in 200 ml deionized water yields 0.01 M PBS, pH 7.4 at 25oC) and MTT were 
purchased from Sigma, St. Louis, Mo., USA. Allicin was purchased from Jiangsu Chiatai 
Qingjiang Pharmaceutical Co., Ltd., China. Spectra/Por® dialysis membrane, 12,000–14,000 
molecular weight cut off, was purchased from Spectrum Laboratories Inc., Rancho 
Dominguez, Canada. Pure platinum electrodes were fabricated by Damas, Cairo, Egypt. 













2.2.1. Electropolymerization of allicin-loaded PPY. 
An electrochemical polymerization cell was constructed as demonstrated in Figure S1. 22.3 
mg of allicin and 0.63 ml of pyrrole were dissolved in 10 ml of deionized water. Two pure 
platinum electrodes were dipped in the solution as shown in Figure S1 and the setup was 
covered with in parafilm. The electrodes were connected with electrical wires to the poles of 
a 9V battery (Philips, Amsterdam, The Netherlands). The electropolymerization process was 
carried out for 6 hours to ensure the complete formation and deposition of the allicin-doped 
PPY at the anode. 
2.2.2. Determination of the drug content of the PPY films. 
The extent of drug loading was performed using an indirect assay method, where the 
working electrode (the film-deposited platinum electrode) was connected to the negative pole 
of the used battery and the counter electrode was connected to the positive counterpart. Both 
electrodes were dipped in a 10 ml of deionized water for 6 hours. An aliquot of 1 ml of the 
aqueous medium was obtained, filtered using 0.45 µm pore filter (Merck, Burlington, MA) 
and analyzed using UV spectrophotometry (Shimadzu, Kyoto, Japan) at 212 nm. 11 mg 
polypyrrole nanoparticles contained 2.2 mg of allicin. 
2.2.3. Formation of the allicin-loaded PPY nanoparticles. 
Drug-loaded PPY films were scratched off the platinum electrode (the anode) into a 
test tube containing an aqueous solution of 0.1% (v/v) Tween 80. Probe sonication (Hielscher 
Ultrasonics GmbH, Teltow, Germany) at 30 kHz and 100% amplitude was conducted for 2 
minutes to obtain a homogenous dispersion. The strong electrostatic bonds formed between 
the PPY matrix and allicin retained the drug in the PPY matrix during the sonication process, 
as confirmed by the negligible absorbance measurement of the drug content in the 
supernatant after centrifugation of the dispersion at 15,000 rpm using UV spectrophotometry 













2.2.4. Characterization of the prepared allicin-loaded PPY nanoparticles. 
2.2.4.1. Particle size and polydispersity index measurements 
The mean particle diameter and polydispersity index (PDI) were determined by 
dynamic light scattering using a Nano ZS® zetasizer (Zetasizer Nano ZS®, Malvern 
instruments, Malvern, UK). The sample was diluted with deionized water until weak 
opalescence was observed. The sample was analyzed using disposable polystyrene cells 
where the measurements were intensity-based and performed at 25°C with an angle detection 
of 173°. Particle size was calculated according to the Brownian movement of the 
nanoparticles utilizing the Stokes–Einstein equation. The measurements were done in 
triplicate and the means and standard deviations were calculated. 
2.2.4.2. Zeta potential measurements 
The surface charge of the nanoparticles was determined by measuring the zeta 
potential. The samples were diluted with 5mM phosphate buffer (pH 7.4) and 1 ml was 
placed in folded capillary zeta cells. The zeta potential was calculated according to laser 
Doppler velocimetry using a Nano ZS® zetasizer. The measurements were done in triplicate 
at 25°C and the means and standard deviations were calculated. 
2.2.4.3. Determination of the morphology of the allicin-loaded PPY nanoparticles using 
transmission electron microscope (TEM) 
The shape and morphology of the prepared nanoparticles were examined using a 
transmission electron microscope (TEM) (Jeol Electron Microscope, JEM-1010, Tokyo, 
Japan). The samples were diluted (1:40 v/v) with deionized water prior to examination. Then, 
a droplet of the diluted dispersion was placed on a carbon film-covered copper grid (200-
mesh). After five minutes, a filter paper placed at the edge of the copper grid was used to 













samples were examined at 120 and 200 kV at a magnification of X50000. No staining was 
required. 
2.2.5. Confirmation of allicin stability in the prepared nanoparticles using 1H-NMR. 
The successful loading of allicin in the nanoparticles after sonication was proven by 
1H-NMR using a 400 MHz NMR spectrometer (Bruker Avance III, Billerica, MA) after 
dispersing the nanoparticles in DMSO at 40°C. 
2.2.6. Electrically controlled drug release. 
The release experiment was carried out by placing the nanoparticles in dialysis bags 
(10,000-12,000 Daltons) immersed in 10 ml of  0.01 M PBS (pH 7.4). The electrical stimulus 
for drug release from the prepared nanoparticles was the voltage application of −9 V for 5s 
followed by 5s of 0 V (for PPY recovery). Such stimulus was found to be most efficient in 
driving the drug out while minimizing the electrochemical damage to the PPY matrix (Luo et 
al., 2009). Samples were taken at specified time intervals, replaced by fresh buffer portions 
and analyzed for allicin content using UV spectrophotometry at 212 nm. The results were 
compared to the release of the drug from the loaded PPY nanoparticles using the same 
experimental setup in the absence of the electrical trigger.  
2.2.7. Determination of the cytotoxicity and the phototoxicity of the allicin-loaded PPY 
nanoparticles. 
2.2.7.1. Cell culture 
Human liver carcinoma HepG2 cell line was obtained from the holding company for 
biological products and vaccines VACSERA (Giza, Egypt). Cells were maintained at 37°C 
under a humidified 5% CO atmosphere in RPMI medium containing 10% FBS and 1% 
penicillin-streptomycin antibiotic mixture (100 IU penicillin and 100 µg streptomycin) 
(Theriault et al., 1999). 













The viability of HepG2 cells in the presence of allicin and allicin-PPY nanoparticles 
complex (Allicin-PPY) was evaluated by performing MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide) assay (Farid et al., 2014; Metwally et al., 2016). HepG2 cells 
were seeded into 96-well culture plates (∼7000 cells/well) containing Roswell Park 
Memorial Institute medium (RPMI) and 10% fetal bovine serum (FBS), allowed to adhere, 
and maintained at 37°C for 24 hrs. Then, the media were replaced with the test and control 
media. Test media were prepared by adding the intended volume of the test samples (aqueous 
solutions) in RPMI media containing fetal bovine serum in a concentration that reaches 2% 
upon addition (final FBS concentration is 2%). Control media (specific control for each test) 
were prepared in the same way as the test media but the added test samples were replaced by 
the same volume of the plain solvent (i.e. sterilized distilled water). Two concentrations of 
allicin (50 µg/ml and 100 µg/ml) as well as the corresponding concentrations of allicin-PPY 
nanoparticles (50/250 µg/ml and 100/500 µg/ml, respectively) were examined simultaneously 
with their controls (4 wells for each test and control medium). The plates were incubated at 
37°C under 5% CO2 atmosphere. After 48 h, test and control media were replaced by phenol 
red-free (colorless) RPMI media containing 0.05% MTT (100 µL for each well) and 
incubated at 37°C for 3–4 h. At the end of the incubation period, MTT media were removed 
and the purple formazan crystals formed were solubilized by adding dimethyl sulphoxide 
(DMSO) (200 µL). The concentration of formazan in each culture well was measured from 
its absorbance at 570 nm using ELISA microplate reader Biotek Elx800, USA. Being directly 
proportional to formazan concentration, viability was calculated by dividing the mean 
readings of test media-treated wells by those of their specific controls (in percentage). To 
evaluate photocytotoxicity, identical experiments were performed after 48 h., and before the 
MTT step, test and control media were replaced by phenol red-free RPMI media (100 µL per 













GMBH, Nurnberg, Germany) (covering a wide range of wavelengths in the UV and NIR 
regions, 1W) for 30 minutes. After irradiation, media were replaced with RPMI media 
containing 10% FBS and incubated at 37°C under 5% CO2 atmosphere for 24 h., then MTT 
step was applied as mentioned above. All cytotoxicity and photocytotoxicity experiments 
were carried out under the same conditions. Experiments were repeated at least three times 
and means and standard deviations are reported. 
3. Results and Discussion 
3.1. Preparation and characterization of allicin-loaded PPY nanoparticles. 
Drug-loaded PPY nanoparticles were successfully prepared using 
electropolymerization. Allicin (Figure 1B) is negatively charged and can dope positively 
charged PPY (Durlak et al., 2016), and the nanoparticles produced had a negative 
zetapotential of -9.77 ± 1.3 mV which may be beneficial for the colloidal stability of the 
nanoparticles due to charge-charge repulsion (Mehanny et al., 2016). Transmission electron 
microscopy (TEM) imaging of the nanoparticles and revealed their pseudo-spherical 
morphology. The particles sizes of the nanoparticles determined by TEM (ca. 40-180 nm, 
Figure 2A and 2B) were smaller than those determined by dynamic laser scattering (DLS) 
which estimated particle sizes to be 275 ± 34 nm and a low PDI of 0.216 ± 0.1 (Figure 2C). 
This disparity in size is because  TEM imaging relies upon dry/dehydrated particles on a 
hydrophobic carbon-coated grid (which can yield a lower volume nanoparticles and even 
enhance the particles aggregation as shown in Figure 2B) (Lao et al., 2010); and DLS 
measurements are carried out on hydrated samples and it is an intensity-based particle size 
measurement technique which relies on Raleigh’s equation in which the intensity of scattered 
light is proportional to the diameter of particles and consequently biased to larger particles 













The loading of allicin in the PPY matrix was confirmed by 1H-NMR analysis, where 
the characteristic peaks of allicin at 3.5-4 ppm and 4.5-5.5 ppm corresponding to the –CH2 
groups located next to the sulphur atoms and the hydrogens of the -CH=CH- groups, 
respectively were clearly visible in the 1H-NMR spectra of the allicin loaded-nanoparticles 
(Figure S2) (Lu et al., 2014; Soumya et al., 2018). 
3.2. Electrochemically-triggered delivery of allicin. 
Electroactive drug delivery devices where the delivery of the therapeutic can be 
controlled in an on/off fashion are particularly interesting as they have the potential to control 
the chonopharmacology of the drug in line with the chronobiology of the condition to be 
treated. A variety of drugs have been delivered from PPY matrices when exposed to electrical 
fields which encourage migration of ions into and out of the polymer matrix (Ateh et al., 
2006). Control electrochemical release experiments (described in section 2.2.2.) show that 11 
mg polypyrrole nanoparticles contained 2.2 mg of allicin. Over the period of an hour ca. 25% 
of the allicin load was released from the nanoparticles by passive leaching of the drug from 
the matrix, whereas, when exposed to an electrical field all of the allicin was released from 
the allicin-loaded PPY nanoparticles (Figure 3). These results demonstrate the potential of 
the nanoparticles to deliver a therapeutically relevant dose of allicin, particularly if the 
nanoparticles were locally delivered to tissues. 
3.3. Cytotoxicity and photocytoxicity of the allicin-loaded PPY nanoparticles. 
Allicin and allicin-PPY nanoparticles (50 µg/ml, 100 µg/ml and 50/250 µg/ml, 
100/500 µg/ml, respectively) had no significant effect (p < 0.05) on HepG2 cells under dark 
conditions. Free allicin resulted in slight reductions in cell viability when increasing its 
concentration under the applied irradiation conditions. In contrast, irradiation of allicin-PPY 
treated cells (50/250 µg/ml and 100/500 µg/ml) under the same irradiation conditions led to 













(Figure 4). This decrease in cell viability could be attributed to the photothermal activity of 
PPY nanoparticles (Wang et al., 2015; Wang et al., 2016). Visible-NIR light spectroscopy 
showed allicin-loaded PPY nanoparticles absorb light in the NIR region (Figure S3). Since 
there is a wide IR band in the white light spectrum, a photothermal action is exerted by the 
PPY nanoparticles leading to hyperthermia of the cells which results in cell death (Liu et al., 
2016). Therefore, allicin-loaded PPY nanoparticles can be used at a relatively high 
concentration (up to 500 µg/ml) with photothermal activity under conventional white light. 
4. Conclusion 
The dual stimuli-responsive nanoparticles for anticancer therapy reported here 
represent an interesting potential platform for the treatment of cancer and a variety of other 
conditions. It would be possible to harness the utility of the photothermal effect of the PPY 
nanoparticles on other cells displaying undesirable behavior to treat a variety of medical 
conditions. Although allicin was used as a model anticancer drug (primarily because it is 
straightforward to quantify its release using UV-vis spectroscopy), it is noteworthy that a 
wide variety of other bioactive molecules could be loaded into the polymer nanoparticles 
using the same experimental paradigm. We foresee the potential of the nanoparticles 
described herein to treat a variety of conditions, and moreover, biodegradable versions of 
such nanoparticles (Hardy et al, 2014; Hardy et al., 2015). 
 
Acknowledgements 
We thank the Drug Design Program (DDP), Faculty of Pharmacy at Ain Shams 
University for funding this work, and a Lancaster University Faculty of Science and 
Technology Early Career Internal Grant to support R.M.H and J.G.H. and a Royal Society 














Declaration of Interest 
The authors report no conflicts of interest. 
 
Figure Captions: 
Figure 1. Structures of the components of the drug delivery system. A) PPY. B) Allicin. 
Figure 2. Size determination of the nanoparticles. A and B) TEM images of the allicin-
loaded PPY nanoparticles. C) DLS data of particle size distribution and polydispersity index 
of the allicin-loaded PPY nanoparticles. 
Figure 3. In vitro validation of the electrochemically-triggered release of allicin from allicin-
loaded PPY nanoparticles. 
Figure 4. In vitro validation of the photothermal toxicity of the PPY nanoparticles. 
Assessment of the cytotoxicity of allicin and allicin-loaded PPY (Allicin-PPYNP) 
nanoparticles towards HepG2 cells in the absence or presence of light. 
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